Climb Bio, Inc. (CLYM) Form 8-K — Jul 1, 2026
On June 29, 2026, Climb Bio, Inc. announced that Andrew Levin resigned from the company's board of directors, effective immediately. The board elected Breanna O'Reilly, Ph.D., to fill the vacancy, with her term expiring at the 2027 annual meeting of stockholders. Dr.
Key figures
- Vesting term years
- 3
- Option grant shares
- 70284
- Annual cash retainer
- $40,000
- Option exercise price
- $13.36
Price after filing
1 day: -2.9%7 days: +1.0%30 days: -9.1%
Close on the filing date to close N calendar days later (from $13.29). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.